Details of the Drug

General Information of Drug (ID: DMB4SSZ)

• Drug Name: P-BCMA-101

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1/2	[1]

• Drug Type: CAR T Cell Therapy
• Cross-matching ID:
  DrugBank ID: DB17371
  TTD ID: D09JKN

References

• [1] ClinicalTrials.gov (NCT03288493) P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)